• Clinical Outcome Of Tavr Patients With The Use Of Triguard 3 Ce Approved Cerebral Embolic Protection Device: Results From The First 50 Consecutive Cases In A Single-centre.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details